Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

BACKGROUND: Malignant pleural mesothelioma (MPM) is a biologically highly aggressive tumor arising from the pleura with a dismal prognosis. Cisplatin is the drug of choice for the treatment of MPM, and carboplatin seems to have comparable efficacy. Nevertheless, cisplatin treatment results in a resp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Mairinger, Fabian D., Schmeller, Jan, Borchert, Sabrina, Wessolly, Michael, Mairinger, Elena, Kollmeier, Jens, Hager, Thomas, Mairinger, Thomas, Christoph, Daniel C., Walter, Robert F.H., Eberhardt, Wilfried E.E., Plönes, Till, Wohlschlaeger, Jeremias, Jasani, Bharat, Schmid, Kurt Werner, Bankfalvi, Agnes
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper: Pathology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5976462/
https://ncbi.nlm.nih.gov/pubmed/29854276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24962
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller